Search

Author/Creator Zager, Jonathan S.

2. Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis. (7th November 2021)

Authors:
Kolla, Avani M.; Vitiello, Gerardo A.; Friedman, Erica B.; Sun, James; Potdar, Aishwarya; Daou, Hala; Farrow, Norma E.; Farley, Clara R.; Vetto, John T.; Han, Dale; Tariq, Marvi; Beasley, Georgia M; Contreras, Carlo M.; Lowe, Michael; Zager, Jonathan S.; Osman, Iman; Berman, Russell S.; Liebman, ...
Journal:
Cancer control
Issue:
Volume 28(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Active surveillance of patients who have sentinel node positive melanoma: An international, multi‐institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT‐2). Issue 13 (7th April 2021)

Authors:
Broman, Kristy Kummerow; Hughes, Tasha; Dossett, Lesly; Sun, James; Kirichenko, Dennis; Carr, Michael J.; Sharma, Avinash; Bartlett, Edmund K.; Nijhuis, Amanda A. G.; Thompson, John F.; Hieken, Tina J.; Kottschade, Lisa; Downs, Jennifer; Gyorki, David E.; Stahlie, Emma; van Akkooi, Alexander; Oll...
Journal:
Cancer
Issue:
Volume 127:Issue 13(2021)
Page Start:
2251
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma. Issue 18 (2nd June 2015)

Authors:
Smith, Franz O.; Yue, Binglin; Marzban, Suroosh S.; Walls, Brooke L.; Carr, Michael; Jackson, Ryan S.; Puleo, Christopher A.; Padhya, Tapan; Cruse, C. Wayne; Gonzalez, Ricardo J.; Sarnaik, Amod A.; Schell, Michael J.; DeConti, Ronald C.; Messina, Jane L.; Sondak, Vernon K.; Zager, Jonathan S.
Journal:
Cancer
Issue:
Volume 121:Issue 18(2015)
Page Start:
3252
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. BRAF inhibition for advanced locoregional BRAF V600E mutant melanoma: a potential neoadjuvant strategy. Issue 1 (February 2016)

Authors:
Sloot, Sarah; Zager, Jonathan S.; Kudchadkar, Ragini R.; Messina, Jane L.; Benedict, Jacob J.; Gonzalez, Ricardo J.; DeConti, Ronald; Turner, Leslie M.; McCardle, Timothy; Smalley, Keiran S.M.; Weber, Jeffrey S.; Sondak, Vernon K.; Gibney, Geoffrey T.
Journal:
Melanoma research
Issue:
Volume 26:Issue 1(2016)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Issue 1 (3rd October 2018)

Authors:
Jeter, Joanne M.; Bowles, Tawnya L.; Curiel‐Lewandrowski, Clara; Swetter, Susan M.; Filipp, Fabian V.; Abdel‐Malek, Zalfa A.; Geskin, Larisa J.; Brewer, Jerry D.; Arbiser, Jack L.; Gershenwald, Jeffrey E.; Chu, Emily Y.; Kirkwood, John M.; Box, Neil F.; Funchain, Pauline; Fisher, David E.; Kendra...
Journal:
Cancer
Issue:
Volume 125:Issue 1(2019)
Page Start:
18
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: A single institution experience. Issue 5 (19th November 2013)

Authors:
Forster, Meghan R.; Rashid, Omar M.; Perez, Matthew C.; Choi, Junsung; Chaudhry, Tariq; Zager, Jonathan S.
Journal:
Journal of surgical oncology
Issue:
Volume 109:Issue 5(2014:Apr. 01)
Page Start:
434
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗